Thematics Asset Management Sells 10,702 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Thematics Asset Management decreased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 12.9% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 72,508 shares of the medical equipment provider's stock after selling 10,702 shares during the period. Intuitive Surgical comprises approximately 1.7% of Thematics Asset Management's investment portfolio, making the stock its 13th biggest holding. Thematics Asset Management's holdings in Intuitive Surgical were worth $37,846,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Atala Financial Inc bought a new stake in shares of Intuitive Surgical in the fourth quarter valued at about $25,000. Berbice Capital Management LLC acquired a new position in shares of Intuitive Surgical during the 4th quarter worth approximately $26,000. BankPlus Trust Department bought a new position in shares of Intuitive Surgical during the fourth quarter worth approximately $28,000. Hurley Capital LLC acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $28,000. Finally, Summit Securities Group LLC bought a new position in Intuitive Surgical during the 4th quarter worth $30,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

ISRG has been the topic of several analyst reports. Citigroup increased their target price on Intuitive Surgical from $640.00 to $711.00 and gave the stock a "buy" rating in a report on Friday, January 24th. Bernstein Bank increased their price objective on shares of Intuitive Surgical from $655.00 to $700.00 and gave the stock an "overweight" rating in a research note on Monday, January 27th. Jefferies Financial Group upped their price target on shares of Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Truist Financial reduced their price target on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a research report on Wednesday. Finally, CICC Research began coverage on shares of Intuitive Surgical in a research report on Monday, January 27th. They set a "neutral" rating and a $550.00 price objective for the company. Five equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $598.95.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG traded up $5.39 during trading on Friday, hitting $513.52. The stock had a trading volume of 1,246,087 shares, compared to its average volume of 1,609,949. The firm has a fifty day moving average of $513.65 and a two-hundred day moving average of $532.19. Intuitive Surgical, Inc. has a 12 month low of $367.39 and a 12 month high of $616.00. The company has a market capitalization of $182.90 billion, a PE ratio of 80.13, a PEG ratio of 5.85 and a beta of 1.55.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating the consensus estimate of $1.71 by $0.10. The firm had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. During the same quarter last year, the business posted $1.50 EPS. On average, equities analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, CFO Jamie Samath sold 94 shares of the company's stock in a transaction on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the transaction, the chief financial officer now owns 2,630 shares of the company's stock, valued at $1,502,019.30. This represents a 3.45 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Fredrik Widman sold 810 shares of the stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $573.78, for a total value of $464,761.80. Following the transaction, the vice president now owns 473 shares of the company's stock, valued at $271,397.94. The trade was a 63.13 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 33,754 shares of company stock valued at $17,691,621. Insiders own 0.70% of the company's stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.